Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
20 May 2020	Submitted	Original manuscript
20 May 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
23 May 2020	Editorially accepted
8 Jun 2020	Article published	10.1186/s13063-020-04448-2

Back to article page